Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive approach. Advocates often emphasize the opportunity for significant therapeutic outcomes, principally in ailments where conventional medications have proven inadequate. However, this is to consider the significant financial burden associated with CPI stem cell ther